ARCHIVES

Phase III Cyramza Trial Meets OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974

Obituary: Gregory Foltz, Swedish Medical Center Neurosurgeon

July 12, 2013

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

To Wage New War On Cancer, Advocates Plan A Campaign Inspired By Earth Day

October 31, 1997